According to a report published by Fortune Business Insights, titled, “Autism Spectrum Disorder Therapeutics Market: Global Market Analysis, Insights and Forecast, 2018-2026,” the global market is likely to reach US$ 4,612.1 Mn by 2026 owing to the rising incidence of autism spectrum disorder worldwide. The report provides valuable insights into the global market trends and factors that are directly affecting the growth of the market. As per the report, the global autism spectrum disorder therapeutics market was worth US$ 3,293.0 Mn in 2018. Considering the increasing awareness programs regarding this particular disorder and less availability of treatment options, the global market is expected to rise at a moderate CAGR of 4.3% during the forecast period (2019-2026).

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/autism-spectrum-disorder-therapeutics-market-101207

Key Players Operating in The Autism Spectrum Disorder Therapeutics Market Include:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

• Applied Behavior Consultants,
• Allergan,
• Pfizer Inc.,
• Q BioMed Inc,
• Fusion Autism Center,
• AstraZeneca,
• Hopebridge, LLC.,
• Johnson & Johnson Services, Inc.,
• Behavior Innovations,
• Eli Lilly and Company,
• Otsuka Holdings Co. Ltd.,
• other prominent market players.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/autism-spectrum-disorder-therapeutics-market-101207

The report further states that the number of children diagnosed with autism is increasing day by day across the globe. This, combined with favorable reimbursement scenario, will increase the demand for applied behavioral analysis therapies. Such therapies aid in improving learning and physical disabilities in autistic children. Furthermore, FDA approvals of numerous medicines that are used to manage autism spectrum disorder are expected to propel the global autism spectrum disorder therapeutics market during the forecast period.

Autistic Disorder Segment to Witness Growth Owing to the Rising Prevalence of the Disease

The global autism spectrum disorder therapeutics market is grouped into drug therapy and communication and behavioral therapy in terms of treatment type. Amongst these, the communication and behavioral therapy segment was in the leading position in the global market. Fortune Business Insights predicts that it will retain its position throughout the forecast period. In terms of type, the autism spectrum disorder therapeutics market is classified into Asperger syndrome, autistic disorder, pervasive development disorder, and others. Out of these, the autistic disorder segment procured the highest autism spectrum disorder therapeutics market share in the year 2018. It is anticipated to witness significant growth in the coming years. This growth is attributed to the increasing prevalence of this disorder.

The global animal health market size is anticipated to reach USD 67.56 billion by 2026 owing to the increasing number of animal health issues worldwide. Animals have always been of immense help to man either as companions or as livestock. With time, man starting adopting animals and keeping them as pets. Animals, alike humans, are susceptible to infections and diseases and require medical aid. As per a recently published report by Fortune Business insights™ titled, “Animal Health Market Size, Share and Global Trend By Product (Drugs, Vaccines, Feed, and Diagnostics), By Animal (Livestock Animals and Companion Animals), By End User (Veterinary Hospitals & Clinics, Animal Care & Rehabilitation Centers, Diagnostic Centers, and Others) and Geography Forecast till 2026” the market size was USD 41.50 billion in 2018 and is anticipated to rise at a CAGR of 6.3%.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/animal-health-market-102371

Major Animal Health Companies in Market are as follows:

• Emergent BioSolutions, Inc.
• Boehringer Ingelheim International GmbH
• Novartis AG
• Virbac
• Intervet Inc.
• Bayer AG
• Zoetis
• Ceva
• Merck & Co., Inc.
• IDEXX Laboratories, Inc.
• CSL Limited
• Elanco

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/animal-health-market-102371

Objectives of the Report

The report on the veterinary healthcare market is based on qualitative and quantitative analysis of factors driving, repelling, and challenging the market. It also provides a well-presented segmentation of the market based on factors such as product, animal, end user, and region. Additionally, the report offers insights about key industry developments and recent innovations in the market with the list of market names and the blueprints chalked out by them to stay ahead of the market competition. Furthermore, the report lists the current animal healthcare market trends and opportunities and is available for sale on the company website.

Major Growth Drivers:

Increasing Number of Pet Owners and Emphasis on Animal Health to Propel Growth

The increasing pet adoption is a major factor propelling animal health market growth. Besides this, analysts at Fortune Business Insights™ say, “the rising prevalence of diseases among animals, especially zoonotic diseases, is likely to promote the animal health market growth during the forecast period.” Zoonotic diseases can be transmitted from animals to humans; a few of which include bubonic plague, salmonellosis, anthrax, rabies, and West Nile virus. Besides this, the rise in the number of animal healthcare clinics worldwide will also drive the market.

Additionally, animals work as test subjects for various medication and drug tests. It is important to test drugs on animals attributable to the fact that research on most prolonged and genetic diseases affecting man cannot be approved for testing on human subjects. Animal studies are used for the development of new surgical techniques such as organ transplantations, new drug testing, and also for nutritional research. The fact that animals serve as research subjects for valuable research on long-lasting deteriorating diseases is further propelling the need to maintain the health of these animals.

The global anti-inflammatory biologics market size is expected to reach USD 149.80 billion by 2027, exhibiting a CAGR of 11.0% during the forecast period. The indication of an inflammatory surplus in patients with COVID-19 along with plentiful neutrophils and macrophages will revivify growth prospects for the anti-inflammatory biologics market share during the forecast period. The ongoing trials for anti-tumor necrosis factor (TNF) antibodies in severe cases of autoimmune inflammatory disease such as rheumatoid arthritis, inflammatory bowel disease, or ankylosing spondylitis will aid the speedy expansion of the market during the forecast period, mentioned by Fortune Business Insights, in a report, titled “Anti-Inflammatory Biologics Market Size, Share & Industry Analysis, By Drug Class (Anti-Tumor Necrosis Factor (TNF), Interleukin Antagonists, Janus Kinase (JAK) Inhibitors, Others), By Application (Rheumatoid Arthritis, Psoriasis, and Others), By Route of Administration (Oral and Injection (Subcutaneous and Intravenous)), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027” the market size stood at USD 64.84 billion in 2019.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/anti-inflammatory-biologics-market-102733

The Report Lists the Prominent Players in the Anti-Inflammatory Biologics Market

• AbbVie Inc.
• Merck & Co., Inc.
• Bristol-Myers Squibb Company
• Johnson & Johnson Services, Inc.
• Pfizer Inc.
• Novartis AG
• UCB S.A.
• Eli Lilly and Company
• Amgen Inc.
• Biogen

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Click here to get the short-term and long-term impact of COVID-19 on this Market.

Please visit:https://www.fortunebusinessinsights.com/anti-inflammatory-biologics-market-102733

Market Driver:

Ongoing Trails for Anti-Tumour Necrosis Factor Therapy to Benefit COVID-19 Patients

The increasing R&D investments by major players for the development of biologics will promote market growth in the forthcoming years. The rising number of deaths from coronavirus (COVID-19) has steered pharmaceutical companies to invest in potential drug candidates. The growing prominence of TNF in acute inflammatory reactions will have a positive impact on the market. Similarly, the ongoing research for anti-TNF therapy in patients with COVID-19 for counteraction and prevention will tremendously influence the market in the forthcoming years. Moreover, the advent of novel biological therapies and monoclonal antibodies by biopharma giants will facilitatethe healthy growth of the marketduring the forecast period. For instance, in December 2019, UCB S.A, a multinational biopharmaceutical company announced positive results from the phase 3 clinical study of Bimekizumab for the treatment of psoriasis. Also, the escalation in applications of existing biologics for rare anti-inflammatory diseases such as lupus, diffuse systemic sclerosis, and others will enhance business scenarios of the market

 The global telerehabilitation market size is poised to rise remarkably in the coming years attributable to the technological advancements in the field of healthcare services in collaboration with information, technology, and communications. Telerehabilitation is a medical service for people preferring to stay at home and avail treatment and services. As per a recent report by Fortune Business Insights, titled, “Telerehabilitation Market Size, Share and Covid-19 Impact Analysis, By Type (Products, Services), By Application (Occupational Therapy, Physical Therapy, Chronic Diseases, and Others), By End-User (Healthcare Facilities and Homecare); and Regional Forecast, 2020-2027,” the market value stood at USD 3.32 billion in 2019 and is expected to rise at a CAGR of 13.4% to reach USD 9.13 billion by 2027. The forecast period is set between 2020 to 2027.

Please visit: https://www.fortunebusinessinsights.com/telerehabilitation-market-103112

As per Fortune Business Insights™, some of the significant players in this market include:

• MIRA Rehab Limited (UK)
• (United States)
• Doctor On Demand, Inc. (United States)
• Care Innovations, LLC. (United States)

• American Well (United States)
• NeoRehab
• Hinge Health, Inc. (United States)
• Koninklijke Philips N.V. (Netherlands)
• Other players

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/telerehabilitation-market-103112

Drivers & Restraints-

Increasing Geriatric Population Vulnerable to Various Diseases will Promote Growth

Telerehabilitation can address a wide variety of medical services through the means of telecommunication and technology. This is especially helpful in the case of patients residing in remote locations with mobility issues and for the aged population. The increasing geriatric population is a key factor promoting the telerehabilitation market growth. Additionally, a rise in the patient pool for chronic diseases is also set to aid in the expansion of the market in the coming years.

On the flip side, in several nations, telehealth services do not count as a part of the medical treatment and therefore, it becomes a tedious task to avail reimbursement for such services. The lack of or total absence of proper reimbursement policies for telehealth services are likely to cause hindrance to the market growth in the coming years. 

Nevertheless, the additional beneficiaries associated with this service such as audiology, speech and language therapy, neurophysiology that offer advanced medical ailment are likely to create lucrative growth opportunities for the market in the coming years.

Segment:

Services Segment to Gain Significant Position Owing to Increasing Number of Service Providers:

Based on segmentation by type, the services segment dominated the market in 2019 on account of the rising adoption of telerehabilitation services and the increasing number of service providers.

Major Industry Developments of this Market Include:

January 2019 – The 3.0 version of PHZIO Digital treatment platform was launched by eWellness Healthcare Corporation for telehealth and physiotherapy markets.

April 2018 – TheraNow, a new platform for connecting physical therapists with their patients via teretherapy was launched by Thera Inc.

The global pet insurance market size is projected to reach USD 11.25 billion by 2026. The increasing pet adoption in leading countries across the world will have a direct impact on the growth of the market. According to a report published by Fortune Business Insights, titled “Pet Insurance Market Size, Share & Industry Analysis, By Policy Coverage Type (Accident & Illness, Accident Only, Others), By Animal Type (Dog, Cat, Others), By Provider (Public, Private) and Regional Forecast, 2019-2026,” the market was worth USD 6.05 billion in 2018. Driven by flexibility in product offerings, the market will exhibit a CAGR of 8.0% during the forecast period, 2019-2026.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/pet-insurance-market-101956

A few of the leading companies that are operating in the global market include:

• Trupanion
• Anicom Holdings
• Nationwide Mutual Insurance Company
• ASPCA
• Healthy Paws Pet Insurance, LLC.
• Embrace Pet Insurance Agency, LLC
• Figo Pet Insurance LLC.
• Agria Pet Insurance Ltd
• 24PetWatch
• Pets Best Insurance Services, LLxC.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/pet-insurance-market-101956

The pet insurance market will benefit from the increasing pet adoption in leading countries across the world. Pet insurance refers to a policy that covers medical as well as accidental factors that is associated with the pets. The emphasis on the well-being and health of pets, by private as well as government organizations will create several growth opportunities. The presence of several private organizations offering premium insurance policies will have a positive impact on the growth of the market in the forthcoming years. Several companies are focused on offering novel services as well as concessions in a bid to establishing a stronghold in the market. These factors will aid the growth of the market in the coming years.

The report provides an in-depth analysis of the global pet insurance market. It highlights the latest product launches and recent innovations in the market and states their impact on the growth of the market. The competitive landscape has been discussed in detail and predictions are made with respect to leading companies and products in the coming years. Forecast values have been provided for the market for the period of 2019-2026. The factual figures have been obtained through trusted sources. Moreover, these predictions are made on the basis of extensive research analysis methods, coupled with the opinions of experienced market research professionals.

Increasing Number of Company Mergers and Collaborations to Aid Market Growth

The report encompasses several factors that have contributed to the growth of the market in recent years. It highlights a few of the leading market drivers and analyzes their impact on the market. Among all factors, the increasing number of company mergers and collaborations have had a positive impact on market growth. In October 2019, Petplan, a leading pet insurance provider, announced that it has been acquired by Warnbug Pincus. Warnbug is a leading private equity firm that mainly focuses on growth-oriented investing. With this acquisition, the company will look to outperform its counterparts and in doing so, establish a strong presence in the market. The report highlights a few of the other company mergers that have graced the market in recent years and gauges their impact on the market

The global microfluidic devices market is expected to gain impetus from increasing technological advancements in the biotechnology domain. According to a report by Fortune Business Insights, titled, “Microfluidic Devices Market Size, Share & Industry Analysis, By Device Type (Chips, Sensors, and Others), By Material (Glass, Silicon, PDMS and Others), By Applications (Pharmaceutical & Life Science Research, Diagnosis & Treatment, and Others), By End-user (Diagnostic Centers, Research Institutes, Pharmaceutical and Biotechnology Companies, Healthcare Facilities and Others) and Regional Forecast, 2019-2026,” the market is projected to reach USD 22.65 Billion by 2026, thereby exhibiting a CAGR of 20.5% during the forecast period. However, the global microfluidic devices market size was valued at USD 5.14 Billion in 2018. The report further states that renowned market players are focusing on low-cost materials for manufacturing microfluidic sensors and chips. It would contribute to the market growth in the forthcoming years.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/microfluidic-devices-market-101098

Fortune Business Insights profiles some of the renowned companies operating in the global microfluidic devices market. They are as follows:

• uFluidix
• Perkin Elmer
• Fluidigm
• Blacktrace Holdings Ltd. (Dolomite Microfluidic)
• Micronit
• BioFluidix GmbH‎
• Fluigent
• ALine, Inc.
• Philips
• Other prominent players

Request a Sample Copy of the Global Microfluidic Devices Market Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/microfluidic-devices-market-101098

The report consists of the latest releases and new mechanical enhancements to engage the consumers to settle on instructed business decisions, design, and complete their required executions. It mainly focuses on the microfluidic devices market trends, open entryways, upcoming changes in methodology, and current business and progressions.

Rising Usage of Microfluidic Devices to Boost Growth of Pharmaceutical and Biotechnology Companies Segment

In terms of end-user, the global microfluidic devices market is grouped into pharmaceutical and biotechnology companies, research institutes, diagnostic centers, and healthcare facilities and others. Out of these, the pharmaceutical and biotechnology companies segment is projected to lead the global market by acquiring the highest revenue in terms of share. It would occur due to the increasing manufacturing and usage of sensors, chips, and other microfluidic devices to offer novel and robust devices to the consumers. However, diagnostic centers and research institutes will also grow rapidly during the forecast period by utilizing microfluidic devices for various applications.

Highlights of the Report

• In-depth analysis of various insights, namely, Microfluidic Devices Market trends, growth drivers, opportunities, and other related challenges.
• Comprehensive details of key market players, their core competencies, and market shares.
• The potency of suppliers and buyers to make better business decisions.
• Lists out the market size in terms of volume.

The global autotransfusion devices market size is predicted to reach USD 320.5 million by 2026, exhibiting a CAGR of 3.2% during the forecast period. The shortage of allogeneic blood and surge in invasive surgeries in developed as well as developing countries will boost the autotransfusion devices market trends in the forthcoming years. According to a survey conducted by World Health Organization (WHO) in 2016, the patient group over 60 years had the highest consumption of allogeneic blood, accounting for an estimated 79.0% of the total blood transfusion that took place in the developed regions. Moreover, the increasing number of surgical procedures and surge in critical injuries are factors expected to fuel demand for autotransfusion devices in the foreseeable future.

For more information in the analysis of this report, visit:https://www.fortunebusinessinsights.com/industry-reports/autotransfusion-devices-market-101899

Some of the Major Companies in the Autotransfusion Devices Market are:

• Haemonetics Corporation
• LivaNova PLC
• Medtronic
• Fresenius SE & Co. KGaA
• BD (Becton, Dickinson, and Company)
• Beijing Jingjing Medical Equipment Co., Ltd.
• Other Prominent Players

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/autotransfusion-devices-market-101899

According to the report, published by Fortune Business Insights in a report, titled “Autotransfusion Devices Market Size, Share & Industry Analysis, By Product Type (Autotransfusion Systems and Consumables & Accessories) By Application (Cardiovascular Surgeries, Orthopedic Surgeries, Neurological Surgeries, Obstetrics & Gynecological Surgeries, and Others) By End User (Hospitals and Specialty Clinics & Others) and Regional Forecast, 2019-2026” the market size was valued at USD 249.2 million in 2018.

The report offers valuable insights into all the dominating trends of the global autotransfusion devices market size. It provides a comprehensive synopsis of all the segments and shares analytical statistics on all the regions of the market. The report is put together after a wide-ranging investigation followed by insightful exploration to aid companies, stakeholders, financers, and potential investors. The report provides a clear depiction of the market size to help our readers acknowledge all the potential threats in the market. Besides, it also covers all the latest advancements and development, product launches, acquisitions, and collaborations & partnerships that took place in recent times.

Rising Number of Surgical Procedures to Present Lucrative Opportunities for the Market

The increasing number of surgical procedures due to the utilization of intraoperative & postoperative cell salvage will bolster healthy growth of the market during the forecast period. The rising awareness regarding the complications associated with allogeneic transfusions will contribute positively to the growth of the autotransfusion devices market in the forthcoming years. The rising number of high-bleeding surgeries among patients in developed as well as developing countries will also foster the growth of the market in the forthcoming years.

Table of Content:

• Introduction
  • Research Scope
  • Market Segmentation
  • Research Methodology
  • Definitions and Assumptions
• Executive Summary
• Market Dynamics
  • Market Drivers
  • Market Restraints
  • Market Opportunities
• Key Insights
  • Key Industry Developments- Partnerships, Mergers and Acquisitions
  • Number of Cardiovascular Procedures for Key Countries, 2018
  • Number of Orthopedic Procedures for Key Countries, 2018
  • Number of Obstetrics & Gynecological Procedures for Key Countries, 2018

TOC Continued…

More Trending Topics from Fortune Business Insights:

Global ePharmacy Market Size to Touch US$ 177,794.9 Mn by 2026; Growth Opportunities Witnessed Around the World to Support Expansion

Wearable Medical Devices Market Worth $139,353.6 Million by 2026, at 24.7% CAGR; Superior Treatment & Diagnostic Outcomes to Spur Demand, Fortune Business Insights™

The rising prevalence of mobility disability and increasing demand technological advancements in wheelchair are is driving the global market says Fortune Business Insights in a report, titled “Wheelchairs Market Size, Share and Global Trend by Type (Self-propelled Wheelchairs, Attendant-Propelled Wheelchairs, Powered / Motorized Wheelchair), By End-User (Hospitals & Nursing Homes, Home care Settings, Assisted Living Facilities, Clinics) And Geography Forecast till 2026”. Electric wheelchairs are likely to fuel demandwitness increasing demand among mobility disabled people due to its their various advantages compared to manual wheelchairs

Browse Complete Report Details@ https://www.fortunebusinessinsights.com/industry-reports/wheelchairs-market-100523

Key Players are:

• Invacare Corporation
• AliMed
• Sunrise Medical
• Seating Matters
• Stryker
• DeVilbiss Healthcare

Request Sample PDF@

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/wheelchairs-market-100523

A Variety of Wheelchairs Options Introduced to Meet User Needs

Wheelchairs are majorly electrical or manual operated devices, designed for people with mobility disability concerns that may restrains the movement of the lower body. This can happen due to diseases, injuries, sickness, or disability. Wheelchairs are available in various types and designs to meet the need of the users. Wheelchairs nowadays include meticulous seating adjustments and advanced features, used for specific activities comprising of individualized controls. The introduction of novel features intended at ensuring improved comfort and ease of use will drive the market over the forecast period.

The Wheelchairs wheelchairs market type is segmented into self-propelled wheelchairs, attendant-propelled wheelchairs, and powered wheelchairs on the basis of type. These wheelchairs are widely used by people suffering from mobility disability. Among the type mentioned above, mostly used wheelchairs are powered wheelchairs or power chairs. These wheelchairs require batteries or electric engines to function and are generally used while driving. Rising incidence of diseases and disabilities on a global scale along with technological innovations in wheelchairs are the factors responsible in boosting the global wheelchairs market during the forecast period. In 2017, around 61 million American were suffering from disabilities out of 7 adults 1 was affected with mobility disability. according to the centers Centers for disease control and Prevention (CDC). This statistic is indicative of the rising prevalence of disability. Against this backdrop, experts foresee a high demand for wheelchairs in the coming years.

Porotype Wheelchairs with Advanced Propulsion System Will Witness High Demand

Manual wheelchairs are designed in a way that itthat they requires a push start. pressure Pressure Excreted is given by griping on to the wheel or the rim also called the pushrim for the movement of the chair. The mechanism requires physical effort, which is one of the key deterrents adversely impacting the sale of manual wheelchairs. This However, the same factor is leading to a major shift in demand fortipping scales in favor of the electric wheelchairs salesfrom manual wheelchairs.

More Trending Topics from Fortune Business Insights:

Global ePharmacy Market Size to Touch US$ 177,794.9 Mn by 2026; Growth Opportunities Witnessed Around the World to Support Expansion

Wearable Medical Devices Market Worth $139,353.6 Million by 2026, at 24.7% CAGR; Superior Treatment & Diagnostic Outcomes to Spur Demand, Fortune Business Insights™

A study by the American Diabetes Association (ADA) has found that around 30.3 million people in the U.S. were diagnosed with diabetes. The rising prevalence of chronic diseases such as diabetes, cancer, and others is boosting the global injectable drug delivery market. Fortune Business Insights in a report, titled “INJECTABLE DRUG DELIVERY: GLOBAL MARKET ANALYSIS, INSIGHTS AND FORECAST, 2019-2026” predicts the global market to rise at a remarkable CAGR of 12.8% during the forecast period. The global market was worth US$ 440.5 Bn in 2018, and by the end of 2026, the market is anticipated to reach US$ 1,135.1 Bn.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/injectable-drug-delivery-market-101044

List of players leading the global Injectable Drug Delivery Market include:

• SHL Group AB
• BD
• Insulet Corporation
• Pfizer
• Eli Lilly and Company
• Elcam Medical
• Ypsomed AG
• West Pharmaceutical Services
• Gerresheimer AG

Get Sample PDF:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/injectable-drug-delivery-market-101044

Regional Overview:

Introduction of Novel Injectable Drug Delivery to Propel Growth in North America

Currently, the market in North America is exhibiting the highest CAGR owing to the rapid adoption of advanced and innovative injectable drug delivery. Moreover, injectable drug users are increasing as these devices are preferred owing to their therapeutic and convenience benefits. The amplified prevalence of chronic disorders such as cancer, diabetes, and others is driving the injectable drug delivery market size in North America.

As per the National Cancer Institute, around 1,735,350 cancer cases were registered in the U.S. With the help of an injectable device; chemotherapy drugs are delivered to cancer patients with ease. Another factor responsible for injectable drug delivery growth is the presence of major manufacturers in North America. This further increases the adoption of injectable drug delivery systems.

These manufacturers are planning to develop innovative drug delivery such as auto-injectors, smart wearables, among others in the years to come. Against this backdrop, the market is likely to grow in the forecast period in North America. As per the report, the market was valued at US$ 156.8 Bn in the year 2018.

BD Leads the Market Owing to its Vast Product Portfolio

Among key players, Becton Dickinson boasts an innovative and vast product portfolio which includes pen-injectors, auto-injectors, and others. The company is leading in the global injectable drug delivery market, mainly on account of its global presence.

Other companies are focusing on product innovations to expand their market shares. The key players profiled in the report are SHL Group, BD, Insulet Corporation, Pfizer Inc., Eli Lilly and Company, Elcam Medical, Ypsomed AG, West Pharmaceutical Services, Inc., and Gerresheimer AG. Of these, BD, SHL, and Insulet Corporation hold the maximum share in the global market. The strong presence of these companies will surge the injectable drug delivery revenue in the forecast years. Some of the notable industry developments made by companies which will help the market to grow are:

• West Pharmaceutical Services, Inc., launched a new extension of SMARTDOSE drug delivery platform in November 2017.
• AbbVie Inc. and Eisai Co., Ltd., together announced the launch of an auto-injector device in June 2018. This device is for Humira drug for the treatment of autoimmune diseases.
• EVER NEURO PHARMA GMBH launched D-MINE pump for patients suffering from Parkinson’s disease in July 2019. The device is convenient to use and aims to provide continuous subcutaneous drug delivery.

 Rising prevalence of chronic wounds and increasing availability of advanced wound dressings are propelling the growth of advanced wound dressings market says Fortune Business Insights in a published report titled “Advanced Wound Dressings Market Size, Share and Global Trend By Product Type (Alginate Dressings, Hydrogel Dressings, Film Dressings, Hydrocolloid Dressings, Antimicrobial Dressings, Foam Dressings), Indication (Diabetic Foot Ulcers, Pressure Ulcers, Surgical Wounds), End Users (Hospitals, Clinics, Home Care Settings) and Geography Forecast till 2025.”Global advanced wound dressings market to grow at significant a CAGR of 4.6% From 2018-2025, owing to the constant focus of key players on R&D to launch new products.

some of the key players in the global Advanced Wound Dressings Market:

• Derma Sciences Inc.
• Coloplast Corp
• ConvaTec Inc.
• Tissue Regenix
• Mölnlycke Health Care AB
• Smith & Nephew
• Organogenesis Inc.
• KCI Licensing, Inc

For more information in the analysis of this report, visit:https://www.fortunebusinessinsights.com/industry-reports/advanced-wound-dressings-market-100384

Innovations in Advanced Wound Dressing Will Support Growth

Shifting preference of healthcare practitioners from old-fashioned wound dressing to advanced wound dressing has led to the expansion of advanced wound dressing market. The demand for advanced dressing for managing and treating wounds such as diabetic, lower limb ulcers, foot ulcers, pressure ulcers and others are fuelling demand for advanced wound dressing in the healthcare sector. Rising prevalence of surgical wounds and chronic wounds in developing countries is further fuelling the demand and enabling the growth of the global advanced wound dressings market. Launch of advanced products by the key player is also supporting the growth of advanced wound dressings. The product launch by companies with an aim to offer better comfort and quicker healing to patients with chronic wounds such as diabetic foot ulcers, pressure ulcers, skin abrasions, cavity wounds venous leg ulcers donor sites and post-operative surgical wounds. For instance, Axio Biosolutions launched MaxioCel, a new innovation in wound care dressing made of chitson. This product is expected to fuel demand among patients and medical practitioners which will consequently help in the growth of advanced wound dressings market.

Request a Sample Copy of the Global Advanced Wound Dressings Market Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/advanced-wound-dressings-market-100384

Intoduction of Alginate Dressing to Have Major Contribution in The Global Market

Chronic wounds are also treated by alginate dressing. It is primarily used due to its exponential benefits such as promoting tissue formation, higher efficiency in exudate management, improved healing of the wound. The demand for alginate dressing along with the rising cases of chronic wounds are contributing significantly to the growth of the global advanced wound dressing market. For Instance, in 2017, alginate segment was accounted for 11.8% share of the global advanced wound care market. Further the global wound care dressings market is segmented on the basis of indication into, pressure ulcers, diabetic foot ulcers surgical wounds, and others.